CORRESP Filing
Rein Therapeutics, Inc.
Date: May 21, 2025 · CIK: 0001420565 · Accession: 0001193125-25-123693
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-287342
Letter
Re: Rein Therapeutics, Inc. Registration Statement on Form S-3 File No. 333-287342 Request for Acceleration Ladies and Gentlemen: Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Rein Therapeutics, Inc. (the “ Registrant ”) hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-287342), so that it may become effective at 4:00 p.m. Eastern time on May 22, 2025, or as soon thereafter as practicable, or at such later time as the Registrant or its counsel may orally request via telephone call to the staff.
REIN THERAPEUTICS, INC. 12407 N. Mopac Expy., Suite 250 #390 Austin, Texas 78758 May 21, 2025 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn: Christopher Edwards
Very truly yours,
REIN THERAPEUTICS, INC.
Show Raw Text
CORRESP 1 filename1.htm CORRESP REIN THERAPEUTICS, INC. 12407 N. Mopac Expy., Suite 250 #390 Austin, Texas 78758 May 21, 2025 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn: Christopher Edwards Re: Rein Therapeutics, Inc. Registration Statement on Form S-3 File No. 333-287342 Request for Acceleration Ladies and Gentlemen: Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Rein Therapeutics, Inc. (the “ Registrant ”) hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-287342), so that it may become effective at 4:00 p.m. Eastern time on May 22, 2025, or as soon thereafter as practicable, or at such later time as the Registrant or its counsel may orally request via telephone call to the staff. Very truly yours, REIN THERAPEUTICS, INC. By: /s/ Brian Windsor Name: Brian Windsor, Ph.D. Title: President and Chief Executive Officer cc: Stuart Falber, Wilmer Cutler Pickering Hale and Dorr LLP Molly Fox, Wilmer Cutler Pickering Hale and Dorr LLP